Literature DB >> 790543

Neutralizing antibodies against Escherichia coli and Vibrio cholerae enterotoxins in human milk from a developing country.

J Holmgren, L A Hanson, B Carlson, B S Lindblad, J Rahimtoola.   

Abstract

By means of the adrenal cell assay and the rabbit small-bowel loop technique enterotoxin-neutralizing antibodies were demonstrated in all investigated milk samples from severely undernourished Pakistani women but, with a single exception, not in milk from Swedish mothers. The antibodies belonged to the IgA and IgG classes as observed in an enzyme-linked immunosorbent assay, which also revealed secretory component on specific enterotoxin antibodies, showing that the IgA antibodies were primarily of the secretory type. The epidemiological stituation and experimental data strongly indicate that Escherichia coli enterotoxin rather than immunologically cross-reactive Vibrio cholerae toxin in most cases constituted the antigenic stimulus for the milk antibodies. The presence in the milk of the Pakistani mothers of secretory IgA antibodies against an important diarrheogenic agent may have practical importance for protection of the breast-fed baby and probably also illustrates the frequent intestinal exposure of these women to enterotoxinogenic bacteria. Since enterotoxin antigen is presumed not to enter deeper tissues, the demonstration of secretory antibodies in milk agrees with a proposed homing of intestinally triggered lymphocytes to the mammary gland.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 790543     DOI: 10.1111/j.1365-3083.1976.tb03036.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  15 in total

1.  IgA ASC accumulation to the lactating mammary gland is dependent on VCAM-1 and alpha4 integrins.

Authors:  Elizabeth N Low; Lauren Zagieboylo; Benjamin Martino; Eric Wilson
Journal:  Mol Immunol       Date:  2010-02-19       Impact factor: 4.407

Review 2.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

3.  Breast feeding--the community norm. Report of a workshop.

Authors:  C E Koop; M E Brannon
Journal:  Public Health Rep       Date:  1984 Nov-Dec       Impact factor: 2.792

Review 4.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

5.  Protective properties of anticholera antibodies in human colostrum.

Authors:  A S Majumdar; A C Ghose
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Presence of secretory IgA antibodies to an enteric bacterial pathogen in human milk and saliva.

Authors:  K A Nathavitharana; D Catty; C Raykundalia; A S McNeish
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

7.  IgA antibodies in human milk: epidemiological markers of previous infections?

Authors:  K A Nathavitharana; D Catty; A S McNeish
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

8.  Neutralizing activity against Clostridium difficile toxin in the supernatants of cultured colostral cells.

Authors:  N Wada; N Nishida; S Iwaki; H Ohi; T Miyawaki; N Taniguchi; S Migita
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Antibacterial and antitoxin responses in the serum and milk of cholera patients.

Authors:  A S Majumdar; P Dutta; D Dutta; A C Ghose
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children.

Authors:  Malla R Rao; Remon Abu-Elyazeed; Stephen J Savarino; Abdollah B Naficy; Thomas F Wierzba; Ibrahim Abdel-Messih; Hind Shaheen; Robert W Frenck; Ann-Mari Svennerholm; John D Clemens
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.